查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球经肠营养设备市场（按产品、年龄层、应用、最终用户和地区划分）- 预测至 2030 年
市场调查报告书
商品编码
1730660

全球经肠营养设备市场（按产品、年龄层、应用、最终用户和地区划分）- 预测至 2030 年

Enteral Feeding Devices Market by Type (Feeding Tubes, Pumps: Feeding, Syringes; Consumables), Age, Application, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 302 Pages | 订单完成后即时交付

价格

全球经肠营养设备市场预计将从 2025 年的 29.651 亿美元成长到 2030 年的 39.942 亿美元。

这一市场扩张很大程度上是由医疗技术的进步所推动的，医疗技术的进步使得经肠营养系统更加安全、有效，并且更易于看护者和家庭管理。医疗机构的严格规范确保这些系统符合高安全性和效率标准。促进市场成长的其他因素包括行业竞争、人口变化、经济因素、全球化、以患者为中心的设计、数位整合和永续性考量。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
对价单位 金额（百万美元）
部分 按产品、年龄组、用途、最终用户、地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

预计在 2025 年至 2030 年期间，经肠营养管部分将占据经肠营养设备市场的最大份额。推动这一趋势的关键因素包括慢性病患病率上升、老年人口增长、技术的快速进步、居家医疗激增、儿科应用、营养管理意识增强、监管反应以及医疗保健成本上升。随着这些因素在全球范围内的发展，製造商需要适应和创新以满足不同患者的需求，同时确保在各种临床环境中的安全性和易用性。

2024 年，肿瘤学领域占据经肠营养设备市场的最大份额，预计这一趋势将在预测期内持续下去。影响肿瘤经肠营养实践的因素包括癌症治疗患者的营养支持、术后恢復通讯协定、癌症相关营养不良的管理、技术进步、个人化营养计划、姑息治疗和经肠营养的整合、经济问题、监管支持、患者教育以及其他相关的正在进行的研究和发展。这些因素促进了经肠营养的有效利用，并改善了患者的生活品质和与癌症诊断相关的结果。

预计在预测期内，医院和外科中心将成为经肠营养设备市场中最大的组成部分。这些机构中经肠营养的使用越来越多，主要是因为它对患者的治疗结果有正面的影响，并且可以节省医疗成本。其他因素包括法规遵从性、技术进步、提高病人安全性和舒适度、提高对经肠营养的认识和教育、与电子健康记录(EHR) 的整合、政府倡议、以患者为中心的护理模式以及医疗保健专业人员之间的协作。随着这些因素的发展，经肠营养可能会继续在医院和外科中心的患者照护中发挥重要作用。

预计由日本、印度、中国、韩国、澳洲和其他地区组成的亚太地区将在预测期内显着成长。该地区经肠营养设备市场成长率显着加速。这些因素包括人口变化、经济成长、负担能力提高、技术进步、法律规范、医疗保健意识提高、医疗保健服务的扩展、贸易和市场进入的加强以及各种政府倡议。这些因素共同创造了一个高度活跃的市场，为国内外公司提供了创新和成长机会。

本报告研究了全球经肠营养设备市场，并提供了按产品、年龄组、应用、最终用户和地区分類的趋势详细信息，以及参与市场的公司概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 波特五力分析
  • 监管状况
  • 赎回方案
  • 生态系分析
  • 投资金筹措场景
  • 技术分析
  • 价值链分析
  • 供应链分析
  • 定价分析
  • 专利分析
  • 贸易分析
  • 2025-2026 年重要会议与活动
  • 影响客户业务的趋势和中断
  • 主要相关人员和采购标准
  • 未满足的需求和关键问题
  • 人工智慧对经肠营养设备市场的影响

第六章经肠营养设备市场（依产品）

  • 介绍
  • 经肠营养管
  • 肠道餵食帮浦
  • 肠内注射式帮浦
  • 耗材及配件

第七章经肠营养设备市场（依年龄层）

  • 介绍
  • 新生儿患者
  • 儿科患者
  • 成年患者
  • 老年患者

第 8 章经肠营养设备市场（依应用）

  • 介绍
  • 肿瘤学
  • 胃肠道疾病
  • 神经系统疾病
  • 糖尿病
  • 代谢紊乱
  • 其他的

第九章经肠营养设备市场（依最终用户）

  • 介绍
  • 医院和外科中心
  • 居家照护
  • 门诊治疗环境
  • 其他的

第 10 章经肠营养设备市场（按地区）

  • 介绍
  • 北美洲
    • 宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 宏观经济展望
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十一章竞争格局

  • 介绍
  • 主要参与企业的策略/优势，2020-2024
  • 2020-2024年收益分析
  • 2024年市场占有率分析
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 产品/品牌比较
  • 竞争场景

第十二章 公司简介

  • 主要参与企业
    • FRESENIUS SE & CO. KGAA
    • CARDINAL HEALTH
    • NESTLE SA
    • AVANOS MEDICAL, INC.
    • DANONE SA
    • BOSTON SCIENTIFIC CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • B. BRAUN MELSUNGEN AG
    • CONMED CORPORATION
    • COOK MEDICAL
    • MOOG, INC.
    • BAXTER INTERNATIONAL INC.
    • VYGON
    • ENTERAL ACCESS TECHNOLOGIES LTD.
    • FIDMI MEDICAL
    • LIFEPUM MEDITECH
  • 其他公司
    • APPLIED MEDICAL TECHNOLOGY, INC.
    • AMSINO INTERNATIONAL, INC.
    • OMEX MEDICAL TECHNOLOGY
    • DANUMED MEDIZINTECHNIK GMBH.
    • MEDLINE INDUSTRIES
    • FUJI SYSTEMS CORPORATION
    • KENTEC MEDICAL.
    • DYNAREX CORPORATION
    • VESCO MEDICAL, LLC
    • MEDELA AG
    • ALCOR SCIENTIFIC
    • ROMSONS

第十三章 附录

Product Code: MD 1289

The global market for enteral feeding devices is projected to reach USD 3,994.2 million by 2030, from USD 2,965.1 million in 2025. This expansion is largely driven by advancements in medical technology, which have made enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to market growth include competition within the industry, demographic shifts, economic factors, globalization, patient-centered design, digital integration, and sustainability considerations.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD million)
SegmentsProduct, Age group, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"Enteral feeding tubes to be largest segment during forecast period"

The enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these factors.

"Oncology to surpass other applications during forecast period"

In 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient's quality of life and outcomes pertaining to a cancer diagnosis.

"Hospitals & surgical centers segment to be prevalent during forecast period"

Hospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers.

"Asia Pacific to register significant growth during forecast period"

The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international companies.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level -- 27%, Director-level - 18%, and Others - 55%
  • By Region: North America - 50%, Europe - 20%, Asia Pacific - 15%, Latin America - 10%, and Middle East & Africa - 5%

Prominent players in this market are Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others.

Research Coverage

  • The report studies the enteral feeding devices market based on product, age group, application, end user, and region.
  • The report analyzes drivers, restraints, opportunities, and challenges affecting the market growth.
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
  • The report studies micro markets with respect to their growth trends, prospects, and contributions to the overall market.
  • The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying this Report:

The report aims to assist new entrants, smaller firms, and market leaders in evaluating investment opportunities within the enteral feeding devices market. It offers a thorough analysis of comprehensive data, enabling informed investment decisions and effective risk assessment. By providing detailed market segmentation that includes end-user categories and regional considerations, the report offers tailored insights for precise targeting of specific segments. Additionally, it delivers an extensive evaluation of key trends, challenges, growth factors, and opportunities, empowering strategic decision-making with a clear understanding.

The report provides insights on the following pointers:

  • Market Dynamics: Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enteral feeding devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product & service launches in the enteral feeding devices market
  • Market Development: Comprehensive information about lucrative markets
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the enteral feeding devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 List of secondary sources
      • 2.1.1.2 Key data from secondary sources
      • 2.1.1.3 Objectives of secondary research
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 List of primary sources (demand and supply sides)
      • 2.1.2.2 Supply- and demand-side participants
      • 2.1.2.3 Breakdown of primary interviews (supply side)
      • 2.1.2.4 Breakdown of primary interviews (demand side)
      • 2.1.2.5 Objectives of primary research
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation
      • 2.2.1.2 Approach 2: Customer-based market estimation
      • 2.2.1.3 Approach 3: Primary interviews
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST ASSUMPTIONS
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ENTERAL FEEDING DEVICES MARKET
  • 4.2 ENTERAL FEEDING DEVICES MARKET, BY REGION
  • 4.3 US ENTERAL FEEDING DEVICES MARKET, BY COUNTRY AND END USER
  • 4.4 ENTERAL FEEDING DEVICES MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Benefits and cost-effectiveness of enteral nutrition
      • 5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients
      • 5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases
      • 5.2.1.4 Increasing prevalence of dysphagia
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Complications associated with enteral feeding devices
      • 5.2.2.2 Lack of awareness about feeding tubes
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth opportunities in emerging economies
      • 5.2.3.2 Growing demand for enteral feeding in home care settings
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Insufficient reimbursement policies in emerging economies
      • 5.2.4.2 Shortage of endoscopy specialists
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY LANDSCAPE
    • 5.4.1 REGULATORY ANALYSIS
    • 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 REIMBURSEMENT SCENARIO
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 INVESTMENT AND FUNDING SCENARIO
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Flow generation mechanisms
      • 5.8.1.2 Flow control technologies
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 Smart feeding pumps
      • 5.8.2.2 Feeding tube replacement technologies
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 Patient monitoring systems
      • 5.8.3.2 Digital connectivity
      • 5.8.3.3 Nutrition supplements
  • 5.9 VALUE CHAIN ANALYSIS
    • 5.9.1 RESEARCH AND DEVELOPMENT
    • 5.9.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING
    • 5.9.3 DISTRIBUTION, MARKETING AND SALES, AND AFTER-SALES SERVICES
  • 5.10 SUPPLY CHAIN ANALYSIS
    • 5.10.1 PROMINENT COMPANIES
    • 5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.10.3 END USERS
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
    • 5.11.2 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES OFFERED BY KEY PLAYERS
    • 5.11.3 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.12 PATENT ANALYSIS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 IMPORT SCENARIO (HS CODE 901839)
    • 5.13.2 EXPORT SCENARIO (HS CODE 901839)
  • 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 UNMET NEEDS AND KEY PAIN POINTS
  • 5.18 IMPACT OF AI ON ENTERAL FEEDING DEVICES MARKET

6 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 ENTERAL FEEDING TUBES
    • 6.2.1 NASAL FEEDING TUBES
      • 6.2.1.1 Need for short-term feeding with minimal tube replacement to drive market
    • 6.2.2 ORAL FEEDING TUBES
      • 6.2.2.1 Extensive use in feeding preterm babies to drive market
    • 6.2.3 GASTRIC OR GASTROSTOMY TUBES (G-TUBES)
      • 6.2.3.1 Escalating demand for PEG and PRG tubes to drive market
    • 6.2.4 JEJUNOSTOMY TUBES (J-TUBES)
      • 6.2.4.1 Trend of minimally invasive procedures to drive market
    • 6.2.5 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES)
      • 6.2.5.1 Reduced tube dislodgment and user-friendly feeding to drive market
  • 6.3 ENTERAL FEEDING PUMPS
    • 6.3.1 RAPID GROWTH IN HOME HEALTHCARE TO DRIVE MARKET
  • 6.4 ENTERAL SYRINGE PUMPS
    • 6.4.1 RELIANCE ON TUBE FEEDING TO DRIVE MARKET
  • 6.5 CONSUMABLES & ACCESSORIES
    • 6.5.1 SYRINGES
      • 6.5.1.1 Technological improvements to drive market
    • 6.5.2 EXTENSION SETS
      • 6.5.2.1 Safe and flexible delivery of nutrition, fluids, and medications to drive market
    • 6.5.3 ADAPTERS
      • 6.5.3.1 Focus on biocompatible materials and minimally invasive designs to drive market
    • 6.5.4 NUTRITION STRAWS
      • 6.5.4.1 Emergence of home enteral nutrition programs to drive market

7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP

  • 7.1 INTRODUCTION
  • 7.2 NEONATAL PATIENTS
    • 7.2.1 RISE IN PRETERM BIRTHS TO DRIVE MARKET
  • 7.3 PEDIATRIC PATIENTS
    • 7.3.1 HEIGHTENED CONCERNS OF MALNUTRITION TO DRIVE MARKET
  • 7.4 ADULT PATIENTS
    • 7.4.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET
  • 7.5 GERIATRIC PATIENTS
    • 7.5.1 DEMOGRAPHIC TRENDS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET

8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 ONCOLOGY
    • 8.2.1 INCREASED PREVALENCE OF CANCER TO DRIVE MARKET
  • 8.3 GASTROINTESTINAL DISORDERS
    • 8.3.1 RISE OF IRRITABLE BOWEL SYNDROME AND GASTROESOPHAGEAL REFLUX DISEASE TO DRIVE MARKET
  • 8.4 NEUROLOGICAL DISORDERS
    • 8.4.1 SURGE IN DEMAND FOR CLINICAL NUTRITION THERAPIES TO DRIVE MARKET
  • 8.5 DIABETES
    • 8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO DRIVE MARKET
  • 8.6 METABOLIC DISORDERS
    • 8.6.1 GROWING INCIDENCE OF BURN INJURIES AND SEPSIS TO DRIVE MARKET
  • 8.7 OTHER APPLICATIONS

9 ENTERAL FEEDING DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & SURGICAL CENTERS
    • 9.2.1 RAPID ADOPTION OF ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE MARKET
  • 9.3 HOME CARE
    • 9.3.1 SUBSTANTIAL HOSPITALIZATION COSTS TO DRIVE MARKET
  • 9.4 AMBULATORY CARE SETTINGS
    • 9.4.1 ELEVATED DEMAND FOR SPECIALTY CARE TO DRIVE MARKET
  • 9.5 OTHER END USERS

10 ENTERAL FEEDING DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK
    • 10.2.2 US
      • 10.2.2.1 Presence of major enteral feeding device providers to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK
    • 10.3.2 GERMANY
      • 10.3.2.1 Government initiatives enhancing domestic healthcare system to drive market
    • 10.3.3 FRANCE
      • 10.3.3.1 Escalating demand for early disease diagnosis to drive market
    • 10.3.4 UK
      • 10.3.4.1 Substantial rise in cancer and neurological disorders to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Elevated demand for cost-effective home care solutions to drive market
    • 10.3.6 SPAIN
      • 10.3.6.1 Surge in patients opting for enteral nutrition to drive market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK
    • 10.4.2 CHINA
      • 10.4.2.1 Growing investments in healthcare infrastructure development to drive market
    • 10.4.3 JAPAN
      • 10.4.3.1 Rapidly expanding geriatric population to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 Large patient pool and increased per capita income to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Soaring volume of patients to drive market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Large number of private hospitals to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK
    • 10.5.2 BRAZIL
      • 10.5.2.1 Improving healthcare facilities to drive market
    • 10.5.3 MEXICO
      • 10.5.3.1 Robust healthcare system with universal health coverage to drive growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK
    • 10.6.2 GCC COUNTRIES
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
  • 11.3 REVENUE ANALYSIS, 2020-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
    • 11.4.1 ENTERAL FEEDING TUBES MARKET SHARE
    • 11.4.2 ENTERAL FEEDING PUMPS MARKET SHARE
    • 11.4.3 ENTERAL SYRINGE PUMPS MARKET SHARE
    • 11.4.4 CONSUMABLES & ACCESSORIES MARKET SHARE
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Application footprint
      • 11.5.5.5 Age group footprint
      • 11.5.5.6 End user footprint
  • 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024
      • 11.6.5.1 List of start-ups/SMEs
      • 11.6.5.2 Competitive benchmarking of start-ups/SMEs
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.8 PRODUCT/BRAND COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 FRESENIUS SE & CO. KGAA
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Expansions
        • 12.1.1.3.2 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 CARDINAL HEALTH
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches and approvals
        • 12.1.2.3.2 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 NESTLE S.A.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 MnM view
        • 12.1.3.3.1 Key strengths
        • 12.1.3.3.2 Strategic choices
        • 12.1.3.3.3 Weaknesses and competitive threats
    • 12.1.4 AVANOS MEDICAL, INC.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product launches and approvals
        • 12.1.4.3.2 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 DANONE S.A.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 BOSTON SCIENTIFIC CORPORATION
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Deals
        • 12.1.6.3.2 Expansions
    • 12.1.7 BECTON, DICKINSON AND COMPANY
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches and approvals
    • 12.1.8 B. BRAUN MELSUNGEN AG
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 CONMED CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Deals
    • 12.1.10 COOK MEDICAL
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 MOOG, INC.
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 BAXTER INTERNATIONAL INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Deals
    • 12.1.13 VYGON
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Deals
    • 12.1.14 ENTERAL ACCESS TECHNOLOGIES LTD.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Other developments
    • 12.1.15 FIDMI MEDICAL
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Product launches and approvals
    • 12.1.16 LIFEPUM MEDITECH
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 APPLIED MEDICAL TECHNOLOGY, INC.
    • 12.2.2 AMSINO INTERNATIONAL, INC.
    • 12.2.3 OMEX MEDICAL TECHNOLOGY
    • 12.2.4 DANUMED MEDIZINTECHNIK GMBH.
    • 12.2.5 MEDLINE INDUSTRIES
    • 12.2.6 FUJI SYSTEMS CORPORATION
    • 12.2.7 KENTEC MEDICAL.
    • 12.2.8 DYNAREX CORPORATION
    • 12.2.9 VESCO MEDICAL, LLC
    • 12.2.10 MEDELA AG
    • 12.2.11 ALCOR SCIENTIFIC
    • 12.2.12 ROMSONS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 US: TOTAL NUMBER OF PRETERM BIRTHS, 2015-2021
  • TABLE 3 DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045
  • TABLE 4 GLOBAL CANCER INCIDENCE, 2015-2040
  • TABLE 5 US: GERIATRIC POPULATION, 2022-2050 (MILLION)
  • TABLE 6 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING DEVICES
  • TABLE 7 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
  • TABLE 14 AVERAGE SELLING PRICE TREND OF G-TUBES OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • TABLE 15 AVERAGE SELLING PRICE TREND OF J-TUBES OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • TABLE 16 AVERAGE SELLING PRICE TREND OF NUTRITION STRAWS OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • TABLE 17 AVERAGE SELLING PRICE TREND OF ENTERAL SYRINGES OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • TABLE 18 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY REGION, 2022-2024 (USD)
  • TABLE 19 PATENT ANALYSIS
  • TABLE 20 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 21 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 22 KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 23 KEY REQUIREMENTS OF STAKEHOLDERS WHEN BUYING ENTERAL FEEDING DEVICES
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE (%)
  • TABLE 25 BUYING CRITERIA FOR TOP THREE END USERS (%)
  • TABLE 26 UNMET CUSTOMER NEEDS AND KEY PAIN POINTS
  • TABLE 27 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 28 ENTERAL FEEDING TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 29 ENTERAL FEEDING TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 NORTH AMERICA: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 EUROPE: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 LATIN AMERICA: ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 MIDDLE EAST & AFRICA: ENTERAL FEEDING TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 ENTERAL FEEDING TUBES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 36 MAJOR BRANDS OF NASAL FEEDING TUBES AVAILABLE IN MARKET
  • TABLE 37 NASAL FEEDING TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 38 NASAL FEEDING TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 LATIN AMERICA: NASAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA: NASAL FEEDING TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 ORAL FEEDING TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 ORAL FEEDING TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 EUROPE: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: ORAL FEEDING TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA: ORAL FEEDING TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 52 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 NORTH AMERICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 EUROPE: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 LATIN AMERICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 MIDDLE EAST & AFRICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 59 JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 EUROPE: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 LATIN AMERICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 MIDDLE EAST & AFRICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 65 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 EUROPE: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 LATIN AMERICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY REGION, 2023-2030 (USD MILLION)
  • TABLE 72 MAJOR BRANDS OF ENTERAL FEEDING PUMPS AVAILABLE IN MARKET
  • TABLE 73 ENTERAL FEEDING PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 74 NORTH AMERICA: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 EUROPE: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 LATIN AMERICA: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 MIDDLE EAST & AFRICA: ENTERAL FEEDING PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 79 ENTERAL FEEDING PUMPS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 80 ENTERAL SYRINGE PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY 2023-2030 (USD MILLION)
  • TABLE 82 EUROPE: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 LATIN AMERICA: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 MIDDLE EAST & AFRICA: ENTERAL SYRINGE PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 86 ENTERAL SYRINGE PUMPS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 87 MAJOR BRANDS OF CONSUMABLES AVAILABLE IN MARKET
  • TABLE 88 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 CONSUMABLES & ACCESSORIES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 96 SYRINGES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 97 NORTH AMERICA: SYRINGES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 EUROPE: SYRINGES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: SYRINGES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 LATIN AMERICA: SYRINGES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 101 MIDDLE EAST & AFRICA: SYRINGES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 102 EXTENSION SETS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 103 NORTH AMERICA: EXTENSION SETS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 EUROPE: EXTENSION SETS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: EXTENSION SETS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 LATIN AMERICA: EXTENSION SETS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: EXTENSION SETS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 108 ADAPTERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 109 NORTH AMERICA: ADAPTERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 EUROPE: ADAPTERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: ADAPTERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 LATIN AMERICA: ADAPTERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: ADAPTERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 114 NUTRITION STRAWS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 115 NORTH AMERICA: NUTRITION STRAWS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 EUROPE: NUTRITION STRAWS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: NUTRITION STRAWS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 LATIN AMERICA: NUTRITION STRAWS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 MIDDLE EAST & AFRICA: NUTRITION STRAWS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 120 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2023-2030 (USD MILLION)
  • TABLE 121 NEONATAL PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 122 PEDIATRIC PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 123 ADULT PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 124 GERIATRIC PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 125 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 126 ONCOLOGY: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 127 LIST OF DIGESTIVE SYSTEM-RELATED DISEASES/DISORDERS
  • TABLE 128 GASTROINTESTINAL DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 129 NEUROLOGICAL DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 130 NEW DIABETES CASES, BY COUNTRY, 2022
  • TABLE 131 TOP 10 COUNTRIES WITH HIGHEST PROPORTION OF PATIENTS WITH TYPE 1 DIABETES
  • TABLE 132 DIABETES: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 133 METABOLIC DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 134 OTHER APPLICATIONS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 135 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 136 HOSPITALS & SURGICAL CENTERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 137 HOME CARE: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 138 AMBULATORY CARE SETTINGS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 139 OTHER END USERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 140 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 141 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 142 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 145 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 146 US: KEY MACRO INDICATORS
  • TABLE 147 US: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 148 CANADA: KEY MACRO INDICATORS
  • TABLE 149 CANADA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 150 EUROPE: MACROECONOMIC OUTLOOK
  • TABLE 151 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 152 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 153 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 154 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 155 GERMANY: KEY MACRO INDICATORS
  • TABLE 156 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 157 FRANCE: KEY MACRO INDICATORS
  • TABLE 158 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 159 UK: KEY MACRO INDICATORS
  • TABLE 160 UK: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 161 ITALY: KEY MACRO INDICATORS
  • TABLE 162 ITALY: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 163 SPAIN: KEY MACRO INDICATORS
  • TABLE 164 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 165 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • TABLE 167 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 171 CHINA: KEY MACRO INDICATORS
  • TABLE 172 CHINA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 173 JAPAN: KEY MACRO INDICATORS
  • TABLE 174 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 175 INDIA: KEY MACRO INDICATORS
  • TABLE 176 INDIA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 177 AUSTRALIA: KEY MACRO INDICATORS
  • TABLE 178 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 179 SOUTH KOREA: KEY MACRO INDICATORS
  • TABLE 180 SOUTH KOREA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 182 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • TABLE 183 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 184 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 185 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 187 BRAZIL: KEY MACRO INDICATORS
  • TABLE 188 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 189 MEXICO: KEY MACRO INDICATORS
  • TABLE 190 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 191 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 192 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 193 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • TABLE 194 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 195 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 196 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 197 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 199 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
  • TABLE 200 ENTERAL FEEDING DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 201 REGION FOOTPRINT
  • TABLE 202 PRODUCT FOOTPRINT
  • TABLE 203 APPLICATION FOOTPRINT
  • TABLE 204 AGE GROUP FOOTPRINT
  • TABLE 205 END USER FOOTPRINT
  • TABLE 206 LIST OF START-UPS/SMES
  • TABLE 207 COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 208 ENTERAL FEEDING DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 209 ENTERAL FEEDING DEVICES MARKET: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 210 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
  • TABLE 211 FRESENIUS SE & CO. KGAA: PRODUCTS OFFERED
  • TABLE 212 FRESENIUS SE & CO. KGAA: EXPANSIONS
  • TABLE 213 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS
  • TABLE 214 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 215 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 216 CARDINAL HEALTH: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 217 CARDINAL HEALTH: DEALS
  • TABLE 218 NESTLE S.A.: COMPANY OVERVIEW
  • TABLE 219 NESTLE S.A.: PRODUCTS OFFERED
  • TABLE 220 AVANOS MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 221 AVANOS MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 222 AVANOS MEDICAL, INC.: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 223 AVANOS MEDICAL, INC.: EXPANSIONS
  • TABLE 224 DANONE S.A.: COMPANY OVERVIEW
  • TABLE 225 DANONE S.A.: PRODUCTS OFFERED
  • TABLE 226 DANONE S.A.: DEALS
  • TABLE 227 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 228 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 229 BOSTON SCIENTIFIC CORPORATION: DEALS
  • TABLE 230 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS
  • TABLE 231 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 232 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 233 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 234 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
  • TABLE 235 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED
  • TABLE 236 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 237 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 238 CONMED CORPORATION: DEALS
  • TABLE 239 COOK MEDICAL: COMPANY OVERVIEW
  • TABLE 240 COOK MEDICAL: PRODUCTS OFFERED
  • TABLE 241 MOOG, INC.: COMPANY OVERVIEW
  • TABLE 242 MOOG, INC.: PRODUCTS OFFERED
  • TABLE 243 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
  • TABLE 244 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED
  • TABLE 245 BAXTER INTERNATIONAL INC.: DEALS
  • TABLE 246 VYGON: COMPANY OVERVIEW
  • TABLE 247 VYGON: PRODUCTS OFFERED
  • TABLE 248 VYGON: DEALS
  • TABLE 249 ENTERAL ACCESS TECHNOLOGIES LTD.: COMPANY OVERVIEW
  • TABLE 250 ENTERAL ACCESS TECHNOLOGIES LTD.: PRODUCTS OFFERED
  • TABLE 251 ENTERAL ACCESS TECHNOLOGIES LTD.: OTHER DEVELOPMENTS
  • TABLE 252 FIDMI MEDICAL: COMPANY OVERVIEW
  • TABLE 253 FIDMI MEDICAL: PRODUCTS OFFERED
  • TABLE 254 FIDMI MEDICAL: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 255 LIFEPUM MEDITECH: COMPANY OVERVIEW
  • TABLE 256 LIFEPUM MEDITECH: PRODUCTS OFFERED
  • TABLE 257 APPLIED MEDICAL TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 258 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW
  • TABLE 259 OMEX MEDICAL TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 260 DANUMED MEDIZINTECHNIK GMBH: COMPANY OVERVIEW
  • TABLE 261 MEDLINE INDUSTRIES: COMPANY OVERVIEW
  • TABLE 262 FUJI SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 263 KENTEC MEDICAL.: COMPANY OVERVIEW
  • TABLE 264 DYNAREX CORPORATION: COMPANY OVERVIEW
  • TABLE 265 VESCO MEDICAL, LLC: COMPANY OVERVIEW
  • TABLE 266 MEDELA AG: COMPANY OVERVIEW
  • TABLE 267 ALCOR SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 268 ROMSONS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ENTERAL FEEDING DEVICES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DATA
  • FIGURE 3 RESEARCH DESIGN
  • FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 9 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACRO INDICATORS
  • FIGURE 10 DATA TRIANGULATION
  • FIGURE 11 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2025-2030
  • FIGURE 16 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • FIGURE 17 ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR ENTERAL FEEDING DEVICES DURING FORECAST PERIOD
  • FIGURE 18 HOSPITALS & SURGICAL CENTERS AND US WERE LARGEST SEGMENTS IN 2024
  • FIGURE 19 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 20 ENTERAL FEEDING DEVICES MARKET DYNAMICS
  • FIGURE 21 ADOPTION OF ENTERAL FEEDING TUBES IN PATIENTS SUFFERING FROM PRADER-WILLIE SYNDROME (2024)
  • FIGURE 22 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 23 ECOSYSTEM ANALYSIS
  • FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2019-2023 (USD MILLION)
  • FIGURE 25 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
  • FIGURE 26 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
  • FIGURE 27 VALUE CHAIN ANALYSIS
  • FIGURE 28 SUPPLY CHAIN ANALYSIS
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING TUBES, BY TYPE, 2022-2024 (USD)
  • FIGURE 30 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY TYPE, 2022-2024 (USD)
  • FIGURE 31 AVERAGE SELLING PRICE TREND OF G-TUBES OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • FIGURE 32 AVERAGE SELLING PRICE TREND OF J-TUBES OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • FIGURE 33 AVERAGE SELLING PRICE TREND OF NUTRITION STRAWS OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • FIGURE 34 AVERAGE SELLING PRICE TREND OF ENTERAL SYRINGES OFFERED BY KEY PLAYERS, 2022-2024 (USD)
  • FIGURE 35 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY REGION, 2022-2024 (USD)
  • FIGURE 36 PATENT ANALYSIS
  • FIGURE 37 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • FIGURE 38 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD THOUSAND)
  • FIGURE 39 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
  • FIGURE 41 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 42 AGE-STANDARDIZED RATE OF CANCER, BY REGION, 2022
  • FIGURE 43 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET SNAPSHOT
  • FIGURE 44 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET SNAPSHOT
  • FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2024
  • FIGURE 46 ENTERAL FEEDING TUBES MARKET SHARE ANALYSIS, 2024
  • FIGURE 47 ENTERAL FEEDING PUMPS MARKET SHARE ANALYSIS, 2024
  • FIGURE 48 ENTERAL SYRINGE PUMPS MARKET SHARE ANALYSIS, 2024
  • FIGURE 49 CONSUMABLES & ACCESSORIES MARKET SHARE ANALYSIS, 2024
  • FIGURE 50 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 51 COMPANY FOOTPRINT
  • FIGURE 52 COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024
  • FIGURE 53 EV/EBITDA OF KEY VENDORS
  • FIGURE 54 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 55 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 56 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT
  • FIGURE 57 CARDINAL HEALTH: COMPANY SNAPSHOT
  • FIGURE 58 NESTLE S.A.: COMPANY SNAPSHOT
  • FIGURE 59 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 60 DANONE S.A.: COMPANY SNAPSHOT
  • FIGURE 61 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 62 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 63 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 65 COOK MEDICAL: COMPANY SNAPSHOT
  • FIGURE 66 MOOG, INC.: COMPANY SNAPSHOT
  • FIGURE 67 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT